Breakthrough COVID is a COVID-19 infection that occurs in someone who has been fully vaccinated. The CDC defines it specifically as detection of the virus at least 14 days after completing all recommended vaccine doses, since the body needs that window to build full immune protection. Breakthrough infections were expected from the start, as no vaccine prevents 100% of infections, but they became much more common as the virus evolved and vaccine-generated immunity waned over time.
How Breakthrough COVID Differs From Unvaccinated Infection
The most important thing to know about breakthrough infections is that they tend to be milder than infections in unvaccinated people. About 43% of breakthrough cases in one study of healthcare workers were completely asymptomatic. Among those who did develop symptoms, the most common were fever (62.5%), headache (45.8%), sore throat (27.3%), cough (26.8%), and muscle pain (22%). Loss of smell and taste, which were hallmark symptoms of earlier COVID waves, occurred in only about 11.5% and 5.3% of breakthrough cases respectively.
The real difference shows up in serious outcomes. Research comparing reinfection in unvaccinated people to breakthrough infection in vaccinated people found that the unvaccinated group had nearly twice the rate of hospitalization or death within 28 days (7.31 vs. 4.69 per 1,000 person-days). That gap held across age groups, though it was especially pronounced in people 65 and older, where the rate in unvaccinated individuals was about 37% higher than in vaccinated ones.
Why Breakthrough Infections Happen
COVID vaccines were designed primarily to prevent severe illness and death, not to create an impenetrable barrier against infection. Protection against infection does exist, but it fades. Data published in the New England Journal of Medicine showed that the XBB.1.5-targeted vaccine reached peak effectiveness of about 52% against infection around four weeks after vaccination, then dropped to roughly 33% by ten weeks and just 20% by twenty weeks. The vaccines also performed less well against newer variants like JN.1 compared to the variants they were designed to target.
This waning protection explains why breakthrough infections became increasingly common over time, and why updated boosters are reformulated to match circulating variants. The immune system still recognizes the virus well enough to mount a faster, stronger response than it would without vaccination, which is why severe outcomes remain less likely, but the initial barrier to infection erodes within months.
Who Is Most at Risk
Certain groups face higher odds of both breakthrough infection and severe illness if they do get infected. People who are immunocompromised, whether from medication, organ transplants, cancer treatment, or conditions like HIV, may not build a strong immune response to vaccination in the first place. The CDC notes that immunocompromised individuals may not be protected even when fully up to date on vaccines.
Age remains the single biggest risk factor for severe outcomes. More than 81% of COVID deaths occur in people over 65, and the death rate in that group is 97 times higher than in adults aged 18 to 29. Other conditions that increase risk of severe breakthrough illness include diabetes (type 1 or 2), chronic kidney or liver disease, chronic lung disease, heart conditions, obesity, and a history of smoking.
Transmission From Breakthrough Cases
People with breakthrough infections can still spread the virus, but they spread it significantly less than unvaccinated infected people. A large contact-tracing study from Cologne, Germany found that unvaccinated individuals transmitted the virus to their contacts at three times the rate of fully vaccinated individuals. Vaccinated people who were infected passed the virus to an average of 0.27 contacts, compared to 0.79 contacts per unvaccinated infected person.
Part of the reason is viral load. Vaccinated people who got infected carried measurably less virus in their respiratory tracts. The study measured this using cycle threshold values from PCR tests (higher values mean less virus), and vaccinated individuals averaged 29.5 compared to 25.7 in unvaccinated individuals. Lower viral load generally means less virus shed into the air and a shorter window of peak infectiousness.
Long COVID After Breakthrough Infection
One of the more reassuring findings about breakthrough infections is that they carry a lower risk of long COVID. A large study comparing over 113,000 unvaccinated COVID cases to vaccinated breakthrough cases found that the breakthrough group had a 15% lower risk of developing lingering symptoms in the months after infection. They also had a 34% lower risk of death in the post-acute period. Vaccination doesn’t eliminate the possibility of long COVID, but it meaningfully reduces it.
Testing for Breakthrough Infections
If you suspect a breakthrough infection, timing matters for test accuracy. At-home rapid antigen tests have an overall sensitivity of only about 47% compared to PCR, meaning they miss roughly half of infections that PCR would catch. Their accuracy peaks around three days after symptoms start, when about 59% of antigen tests come back positive. PCR tests peak at the same time point but catch about 83% of cases.
A negative rapid test on the first day of symptoms doesn’t rule out infection. If you have symptoms consistent with COVID, testing again 24 to 48 hours later significantly improves your chances of getting an accurate result. Rapid tests are much better at identifying when someone is actively contagious: compared to viral culture (which measures live, transmissible virus rather than just viral fragments), their sensitivity jumps to about 80%.